GA/T 2071-2023
Forensic sciences—Examination methods for five imidazoline drugs including tetrahydrozoline in biological samples—LC-MS
GA/T 2071-2023
GA/T 2071-2023
GA/T 2071-2023
Determination of cefazolin, cephapirin, cephalexin, cefalonium, cefquinome residues in honey - LC-MS-MS method
GA/T 2071-2023
Determination of cefazolin, cefapirin, cephalexin, cefalonium, cefquinome residues in fugu and eel - LC-MS-MS method
GA/T 2071-2023
GA/T 2071-2023
GA/T 2071-2023
GA/T 2071-2023
GA/T 2071-2023
TETRAHYDROZOLINE HYDROCHLORIDE OPTHALMIC SOLUTION, USP (S/S BY A-A-54607)
GA/T 2071-2023
NAPHAZOLINE HYDROCHLORIDE AND ANTAZOLINE PHOSPHATE OPHTHALMIC SOLUTION (NO S/S DOCUMENT)
GA/T 2071-2023
GA/T 2071-2023
GA/T 2071-2023
Standard for Propiconazole Tebuconazole Imidacloprid (PTI)
GA/T 2071-2023
NAPHAZOLINE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP (SUPERSEDING A-A-53360)
GA/T 2071-2023
Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin
GA/T 2071-2023
TETRAHYDROZOLINE HYDROCHLORIDE OPTHALMIC SOLUTION, USP (S/S BY A-A-54607)
GA/T 2071-2023
OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION, USP (NO S/S DOCUMENT)
GA/T 2071-2023
GA/T 2071-2023
Determination of cefalexin,cephapirin and cefazolin residues in foodstuffs of animal origin for import and export-LC-MS/MS method